AstraZeneca becomes first international company to file Medicare drug pricing suit

AstraZeneca has sued US Health Secretary Xavier Becerra and CMS Administrator Chiquita Brooks-LaSure, claiming that certain provisions of the Inflation Reduction Act, which granted CMS negotiating powers, are unconstitutional and infringed upon the company's property rights.

yahoo.com

Relevant topic timeline:

8/25/2023

AstraZeneca sues US over Medicare drug price negotiation plans

AstraZeneca has sued the U.S. government to block a program that allows Medicare to negotiate lower drug prices, claiming that it would hinder the development of new medicines.

9/21/2023

FTC Sues Private Equity Firm, Anesthesia Provider for Anticompetitive Scheme to Consolidate and Raise Prices in Texas

The Federal Trade Commission has filed a lawsuit against U.S. Anesthesia Partners, Inc. and private equity firm Welsh, Carson, Anderson & Stowe, accusing them of engaging in an anticompetitive scheme to monopolize the anesthesiology market in Texas, drive up prices, and increase their own profits.